XT
VRCA icon

XTX Topco’s Verrica Pharmaceuticals VRCA Stock Holding History

XTX Topco’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$84K Buy
+13,723
New +$85.6K ﹤0.01% 3578
2026
Q1 		– Sell
-14,662
Closed -$122K – 4440
2025
Q4 		$122K Buy
+14,662
New +$81.2K ﹤0.01% 2583
2025
Q3 		– Sell
-1,106
Closed -$5.86K – 3341
2025
Q2 		$5.86K Sell
1,106
-4,604
-81% -$24.8K ﹤0.01% 2252
2025
Q1 		$25.3K Buy
5,710
+902
+19% +$5.83K ﹤0.01% 2103
2024
Q4 		$33.7K Sell
4,808
-18,307
-79% -$201K ﹤0.01% 1963
2024
Q3 		$335K Buy
+23,115
New +$1.04M 0.02% 1113
2023
Q2 		– Sell
-2,262
Closed -$147K – 1885
2023
Q1 		$147K Buy
+2,262
New +$137K 0.03% 1030
2022
Q3 		– Sell
-2,580
Closed -$50K – 1411
2022
Q2 		$50K Buy
+2,580
New +$130K 0.02% 743

Other funds holding VRCA

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $149M AUM 39.81% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

XTX Topco's VRCA Position: Q2 2026 in Review

XTX Topco opened a new position in Verrica Pharmaceuticals (VRCA) in Q2 2026: 13,723 shares worth $84K. The stake represents ﹤0.01% of the portfolio and ranks #3578 among its holdings. This is a return to the name: XTX Topco previously reported a position in VRCA as recently as Q4 2025.

XTX Topco first reported a position in VRCA in Q2 2022 and has held it in 8 quarters since. The position peaked at $335K in Q3 2024. 43 funds tracked by Wall St. Rank hold VRCA as of Q2 2026.

  • XTX Topco held 13,723 shares of Verrica Pharmaceuticals worth $84K as of Q2 2026.
  • Verrica Pharmaceuticals was a new XTX Topco position in Q2 2026.
  • Verrica Pharmaceuticals made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3578 holding.
  • XTX Topco first reported a position in Verrica Pharmaceuticals in Q2 2022 and has held it in 8 quarters since.
  • XTX Topco's Verrica Pharmaceuticals position peaked at $335K in Q3 2024.
  • 43 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.